Maravai LifeSciences
Update in progressMRVI (NasdaqGS)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryBiotechnology
Maravai LifeSciences Holdings, Inc. is a San Diego–based life sciences company that provides products and services used to develop drugs, vaccines, cell and gene therapies, and diagnostics worldwide. It operates two segments: TRILINK, which supplies nucleic acid reagents, oligonucleotides, mRNA tools, enzyme development, and related research products; and CYGNUS, which offers analytical assays, antibody and assay development, impurity and viral clearance kits, and related services.
Company score
- Sentiment
- -0.51
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- -0.62
- Governance
- -0.46
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.28
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- -0.40
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqGS (NMS)
- LocationUnited States
- CEOMr. Bernd Brust
- Founded2014
- Employees415
- Websitewww.maravai.com
Identifiers
- ISINUS56600D1072
- FIGIBBG00Y1DFV91
- CUSIP56600D107
- CIK0001823239